When nations implement pharmaceutical price controls, they reduce pharmaceutical revenues, which then reduces investments in further R&D, limiting future generations’ access to new novel treatments needed to fight diseases such…
Learn MoreIn 2022, the WHO Science Division initiated a horizon scan to identify innovations in science and technology that could improve global health, including to address health needs that are frequently…
Learn MoreH5N1 has received significant attention in mainstream media and the scientific community over the past three months, though it is not a new virus. Recent outbreaks in mink farms appear…
Learn MoreThe federal government has provided about $4.6 trillion to help the nation respond to and recover from the COVID-19 pandemic. Tracking federal spending is complex—especially at this unprecedented magnitude. The…
Learn MoreThis report describes One Health’s response to antimicrobial resistance and provides evidence that the environment plays a key role in the development, transmission and spread of AMR. Prevention is at…
Learn MoreResearch involving pandemic pathogens are crucial to ensure the nation’s ability to prepare for, respond to, and recover from public health threats. A number of incidents and research projects have…
Learn MoreThe GAO (Government Accountability Office) was asked to conduct a technology assessment on pandemic origins. GAO’s technology assessment sought to explore how emerging technologies, such as advanced genomics, could be…
Learn More